In vitro and clinical studies examining the expression of osteopontin in cigarette smoke-exposed endothelial cells and cigarette smokers

BMC Cardiovascular Disorders

Volumn 12, Issue , 2012, Pages

  Bishop, Emma ^a   Theophilus, Eugenia H ^b   Fearon, Ian M ^a  

^a BRITISH AMERICAN TOBACCO   (United Kingdom)

^b R J REYNOLDS TOBACCO COMPANY   (United States)

Author keywords

Atherosclerosis; Endothelial cells; In vitro; MMP 3; Osteopontin; Smoking

Indexed keywords

ASCORBIC ACID; CIGARETTE SMOKE; INTERLEUKIN 6; OSTEOPONTIN; STROMELYSIN;

ADULT; AGED; ARTICLE; CELL CULTURE; CELL VIABILITY; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; OXIDATIVE STRESS; PARTICULATE MATTER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SMOKING; SMOKING CESSATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ADULT; ANTIOXIDANTS; ASCORBIC ACID; BLOTTING, WESTERN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCHEMICAL TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; OSTEOPONTIN; POLYMERASE CHAIN REACTION; SMOKE; SMOKING; SMOKING CESSATION; TIME FACTORS; UP-REGULATION; YOUNG ADULT;

EID: 84866160445     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-12-75     Document Type: Article

References (24)

1. Campell SC, Moffat RJ, Stamford BA. Smoking and smoking cessation- The relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis 2008, 201:255-235.
2. Lao XQ, Jiang CQ, Zhang WS, Adab P, Lam TH, Cheng KK, Thomas GN. Smoking cessation and inflammatory markers in older chinese men: The Guangzhou Biobank Cohort study. Atheroslerosis 2009, 203:304-310.
3. Winkelman BR, von Holt K, Unverdorben M. Smoking and atherosclerotic cardiovascular disease: Part 1: atherosclerotic disease process. Biomarkers Med 2009, 3:411-428.
4. Perfetti TA, Rodgman A. The Complexity of Tobacco and Tobacco Smoke. Beitr Tabakforsch Int 2011, 24:215-232.
5. Wang XL, Scott DA. Mechanisms of cigarette smoking induced pathogenesis: an overview. Molecular Mechanisms of Tobacco-Induced Diseases 2005, 1-6. Nova, New York, Wang XL, Scott DA.
6. Okamoto H. Osteopontin and cardiovascular system. Mol Cell Biochem 2007, 300:1-7. 10.1007/s11010-006-9368-3, 17136480.
7. Heinegard D, Hultenby K, Oldberg A, Reinholt F, Wendel M. Macromolecules in bone matrix. Connect Tissue Res 1989, 21:3-11. 10.3109/03008208909049990, 2691197.
8. Scatena M, Liaw L, Giachelli CM. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007, 27:2302-2309. 10.1161/ATVBAHA.107.144824, 17717292.
9. Singh M, Ananthula S, Milhorn DM, Krishnaswamy G, Singh K. Osteopontin: a novel inflammatory mediator of cardiovascular disease. Frontiers Biosci 2007, 12:214-221.
10. Cho HJ, Cho HJ, Kim HS. Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification. Vasc Biol 2009, 11:206-213.
11. Agnihotri R, Crawford HC, Haro H, Matisian LM, Havrda MC, Liaw L. Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). J Biol Chem 2001, 276:28261-28267. 10.1074/jbc.M103608200, 11375993.
12. Ohmori R, Momiyama Y, Taniguchi H, Takahashi R, Kusuhara M, Nakamura H, et al. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 2003, 170:333-337. 10.1016/S0021-9150(03)00298-3, 14612215.
13. Waller AH, Sanchez-Ross M, Kaluski E, Klapholz M. Osteopontin in cardiovascular disease: a potential therapeutic target. Cardiol Rev 2010, 18:125-131. 10.1097/CRD.0b013e3181cfb646, 20395697.
14. Fearon IM, Faux S. Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. J Mol Cell Cardiol 2009, 47:372-381. 10.1016/j.yjmcc.2009.05.013, 19481547.
15. Chehne F, Oguogho A, Lupattelli G, Palumbo B, Sinzinger H. Effect of giving up cigarette smoking and restarting in patients with clinically manifested atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 2002, 67:333-339. 10.1054/plef.2002.0438, 12445494.
16. Pilz H, Oguogho A, Chehne F, Lupattelli G, Palumbo B, Sinzinger H. Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury (determined via plasma, serum and urinary isoprostane). Thromb Res 2000, 99:209-221. 10.1016/S0049-3848(00)00249-8, 10944241.
17. Parsanejad R, Fields WR, Steichen TJ, Bombick BR, Doolittle DJ. Distinct regulatory profiles of interleukins and chemokines in response to cigarette smoke condensate in normal human bronchial epithelial (NHBE) cells. J Interferon Cytokine Res 2008, 28:703-712. 10.1089/jir.2008.0139, 18937544.
18. Faux SP, Tai T, Thorne D, Xu Y, Breheny D, Gaca M. The role of oxidative stress in the biological responses of lung epithelial cells to cigarette smoke. Biomarkers 2009, 14:90-96. 10.1080/13547500902965047, 19604067.
19. Newland N, Richter A. Agents associated with lung inflammation induce similar responses in NCI-H292 lung epithelial cells. Toxicology In Vitro 2008, 22:1782-1788. 10.1016/j.tiv.2008.07.009, 18684396.
20. Halvorsen B, Lundsagen E, Ueland T, Aukurst P, Tonstad S. Effects of smoking cessation on markers of inflammation and endothelial cell activation amoung individuals with high risk for cardiovascular disease. Scand J Clin Lab Invest 2007, 67:604-611. 10.1080/00365510701283878, 17852807.
21. Lao XQ, Jiang CQ, Zhang WS, Adab P, Lam TH, Cheng KK, Thomas GN. Smoking, smoking cessation and inflammatory markers in older Chinese men: The Guangzhou biobank cohort study. Atherosclerosis 2009, 203:304-310. 10.1016/j.atherosclerosis.2008.06.028, 18692847.
22. White AJ, Duffy SJ, Walton AS, Ng JF, Rice GE, Mukherjee S, Shaw JA, Jennings GL, Dart AM, Kingwell BA. Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary disease. Cardiovasc Res 2007, 75:813-820. 10.1016/j.cardiores.2007.05.003, 17543900.
23. Watson AM, Benton AS, Rose MC, Freishtat RJ. Cigarette smoke alters tissue inhibitor of metalloproteinase 1 and matrix metalloproteinase 9 levels in the basolateral secretion of human asthmatic bronchial epithelium in vitro. J Investig Med 2010, 58:725-729. 3325291, 20305574.
24. La Rocca G, Anzalone R, Magno F, Farina F, Cappello F, Zumo G. Cigarette smoke exposure inhibits extracellular MMP-2 (gelatinase A) activity in human lung fibroblasts. Respir Res 2007, 12:23.